Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hys Ngan is active.

Publication


Featured researches published by Hys Ngan.


British Journal of Obstetrics and Gynaecology | 2009

Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications

Ttc Kwan; Kkl Chan; Amw M. W. Yip; Kf F. Tam; Any Cheung; Sst Lo; Pwh Lee; Hys Ngan

Objectiveu2002 To explore Chinese women’s perceptions of human papillomavirus (HPV) vaccination and their intention to be vaccinated.


Theranostics | 2018

GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade

Mh Yung; Wm Tang; C Cai; Thy Leung; Sf Ngu; Kkl Chan; Dakang Xu; H Yang; Hys Ngan; David W. Chan

Intraperitoneal metastasis is a common occurrence and is usually involved in the poor prognosis of ovarian cancer. Its specific metastatic pattern implies that certain indispensable microenvironmental factors secreted in the peritoneal cavity can direct metastatic ovarian cancer cells to permissive niches for secondary lesion formation. However, the underlying molecular mechanisms are ill defined. Herein, we report that GRO-α and IL-8 are predominately upregulated in culture media derived from either normal or cancerous omenta and are associated with increased ovarian cancer aggressiveness. Methods: OCM was established from culture medium of fresh human omental tissues. Primary and metastatic ovarian cancer cell lines were generated from human tumor tissues and verified by specific antibodies. The functional roles of GRO-α, IL-8, and their specific receptor CXCR2 were examined by neutralizing antibodies, shRNA gene knockdown, CRISPR/Cas9 gene knockout and pharmaceutical CXCR2 inhibitor SB225002. The oncogenic properties of ovarian cancer cells were examined by in vitro and in vivo mouse models. Results: Both GRO-α and IL-8 can activate TAK1/NFκB signaling via the CXCR2 receptor. Intriguingly, TAK1/NFκB signaling activity was higher in metastatic ovarian cancer cells; this higher activity makes them more susceptible to OCM-induced tumor aggressiveness. Treatment of ovarian cancer cells with GRO-α and IL-8 neutralizing antibodies or ablation of CXCR2 by shRNA gene knockdown, CRISPR/Cas9 gene knockout, or CXCR2 inhibitor SB225002 treatment significantly attenuated TAK1/NFκB signaling and decreased in vitro and in vivo oncogenic and metastatic potential, suggesting CXCR2 plays a key role in the GRO-α and IL-8-governed metastatic spreading of ovarian cancer cells in the intraperitoneal cavity. Conclusion: This study highlights the significance of GRO-α and IL-8 as the key chemokines in the peritoneal tumor microenvironment and suggests the utility of targeting their receptor CXCR2 as a potential target-based therapy for peritoneal metastases of ovarian cancer.


Archive | 2016

BCL2A1 plays a biphasic role in ovarian cancer progression: promoting cell survival and inhibiting cell proliferation

R Liang; Mh Yung; Hys Ngan; David W. Chan


Archive | 2016

Identification of MAP30 as a natural AMPK activator in targeting the tumorigenicity and chemoresistance of ovarian cancer cells

Mh Yung; Hys Ngan; David W. Chan


Archive | 2016

Functional characterization of MAP30 protein from bitter melon (Momordica charantia) in combating ovarian cancer oncogenesis and chemoresistance

Mh Yung; Hys Ngan; Dg Hardie; David W. Chan


Archive | 2016

AMP-activated protein kinase gamma-2 (AMPK-g2) subunit modulates AMPK activities to ensure ovarian cancer progression

David W. Chan; Mh Yung; Dg Hardie; Hys Ngan


Archive | 2014

BCL2A1 plays a biphasic role in ovarian cancer progression

R Liang; Hys Ngan; David W. Chan


Archive | 2013

The AMPK/TAK1 signaling axis is indispensable for controlling ovarian cancer cell metabolism and omental metastasis

David W. Chan; C Cai; Mh Yung; Hys Ngan


Archive | 2013

MAP30 protein of momordica charantia functions as a natural AMPK activator in combating tumorigenic and chemoresistant capacities of ovarian cancer

David W. Chan; Mh Yung; Hys Ngan


Archive | 2012

Bitter melon extract (BME) used as natural AMPK activator in inhibiting ovarian cancer cells growth

Mh Yung; David W. Chan; Hys Ngan

Collaboration


Dive into the Hys Ngan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Any Cheung

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Kkl Chan

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

R Liang

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Pwh Lee

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

S Liu

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Thy Leung

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar

Dakang Xu

Shanghai Jiao Tong University

View shared research outputs
Researchain Logo
Decentralizing Knowledge